Massive cancer registry tracks genetic Testing's Real-World impact
NCT ID NCT04529122
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed registry followed nearly 8,000 adults with solid tumors who had next-generation sequencing (NGS) genetic testing. The goal was to collect real-world data linking test results, treatments, and survival. No new drug or intervention was tested; instead, the registry aims to help design future research and improve understanding of cancer care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
7,864 people
The number who actually took part.
- Started
-
Aug 2020
- Finished
-
Apr 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Male and Female adult participants who are diagnosed with solid tumour cancers (at any anatomical location) and at any stage of the disease who have undergone an NGS test.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participant is an adult (according to the age of majority as defined by local regulations) * Participant is currently diagnosed with any type of solid tumour cancer, at any stage of the disease, at the enrollment date (informed consent date) * Participant has undergone NGS testing, no longer than 3 months prior to the enrollment date, irrespective of the availability of test results * Informed consent has been obtained from the participant or legally authorized representative, as per local regulations Exclusion Criteria: -Participant has a prior or current diagnosis of haematological malignancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Solid tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM
Marseille, 13385, France
-
Ac?badem Adana Hospital, Oncology Department
Seyhan/Adana, 01130, Turkey (Türkiye)
-
Ac?badem Maslak Hastanesi Büyükdere
Sar?yer/?stanbul, 34457, Turkey (Türkiye)
-
Adelaide & Meath Hospital, Dublin, Incorporating the National Children's Hospital
Dublin, 24, Ireland
-
Alberta Health Services
Calgary, Alberta, T2N 4N2, Canada
-
Alexandras General Hospital of Athens
Athens, 115 28, Greece
-
American University of Beirut - Medical Center
Beirut, 1107 2020, Lebanon
-
Apollo Hospitals
Chennai, Tamil Nadu, 600035, India
-
Asklepios Klinik Altona
Hamburg, 22763, Germany
-
Ba?c?lar Medipol Mega Üniversite Hastanesi
Istanbul, 34214, Turkey (Türkiye)
-
Beacon Hospital
Dublin, D18 AK68, Ireland
-
Beneficencia Portuguesa de Sao Paulo
São Paulo, 01321-00, Brazil
-
Bhaktivedanta Hospital and research institute
Thane, Maharashtra, 401107, India
-
Bioclinic Thessaloniki
Thessaloniki, 546 22, Greece
-
Blackpool Victoria Hospital
Blackpool, FY3 8NR, United Kingdom
-
Bristol Haematology and Oncology centre
Bristol, BS2 8ED, United Kingdom
-
Bács-Kiskun Vármegyei Oktatókórház
Kecskemét, 6000, Hungary
-
CEMIC
Buenos Aires, C1431FWN, Argentina
-
CH de Cornouailles
Quimper, 29107, France
-
CHI de Toulon - Hôpital Sainte Musse
Toulon, 83056, France
-
CHU Saint Etienne - Hôpital Nord
Saint-Etienne, 42055, France
-
Cebu Doctors' University Hospital
Cebu City, 6000, Philippines
-
Centre Eugene Marquis
Rennes, 35000, France
-
Centre Francois Baclesse
Caen, 14076, France
-
Centre Hospitalier de Béthune-Beuvry
Béthune, 62408, France
-
Centre Hospitalier de Chauny
Chauny, 02300, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Leon Berard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre hospitalier universitaire Dijon-Bourgogne
Dijon, 21079, France
-
Centro de Cancer Pontificie Universidad Catolica de Chile
Santiago, 8330074, Chile
-
Chang Gung Medical Foundation - Kaohsiung
Kaohisung, 833, Taiwan
-
Chu Amiens - Picardie
Amiens, 80054, France
-
Chu Brest - Hôpital Morvan
Brest, 29200, France
-
Chulalongkorn Hospital
Bangkok, 10330, Thailand
-
Chung Gung Memorial Hospital
Taoyuan County, 333, Taiwan
-
Clinica ASTORGA
Medellín, 50010, Colombia
-
Clínica Integral Internacional de Oncología S de RL de CV
Puebla City, Mexico CITY (federal District), Mexico
-
Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico
Jaén, 23007, Spain
-
D'or Instituto de Pesquisa e Educação
Rio de Janeiro, Brazil
-
DRK Kliniken Berlin
Berlin, 12559, Germany
-
East Tallinn Central Hospital
Tallinn, 11312, Estonia
-
Faculty of Med. Siriraj Hosp.
Bangkok, 10700, Thailand
-
Freeman Hospital
New Castle Upon Tyne, NE7 7DN, United Kingdom
-
Fundacion Cardioinfantil
Bogotá, Colombia
-
Fundacion Clinica Valle del Lili
Cali, Colombia
-
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo
Bogota, D.C., 110131, Colombia
-
General Hospital "G.Papanikolaou"
Asvestochóri, 570 10, Greece
-
Gloucestershire Royal Hospital
Gloucester, GL1 3NN, United Kingdom
-
Groupe Hospitalier Public Du Sud De L'Oise GHPSO
Creil, 60109, France
-
Gustave Roussy
Villejuif, 94800, France
-
HELIOS Klinikum Bad Saarow
Bad Saarow, 15526, Germany
-
Hadassah University Hospital - Ein Kerem
Jerusalem, 9112001, Israel
-
Hammoud Hospital
Saida, 6520, Lebanon
-
Hanoi Oncology Hospital
Hanoi, 100000, Vietnam
-
HealthCare Global Enterprises Limited
Banglore, Karnataka, 560027, India
-
Henri Dunant Hospital
Athens, 115 26, Greece
-
Ho Chi Minh City Oncology Hospital
Ho Chi Minh City, Vietnam
-
Hopital Jean Minjoz
Besançon, 25030, France
-
Hopital de La Timone - CHU de Marseille
Marseille, 13385, France
-
Hospital Alemao Oswaldo Cruz
São Paulo, São Paulo, 01323-903, Brazil
-
Hospital CUF Porto
Porto, 4100-180, Portugal
-
Hospital Clinico Universitario Virgen de la Victoria;Servicio de Oncologia
Málaga, 29011, Spain
-
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Hospital Universitario Son Espases
Palma de Mallorca, Balearic Islands, 07014, Spain
-
Hotel Dieu de France
Beirut, 2063 1111, Lebanon
-
Hôpital Franco-Britannique- Fondation Cognacq-Jay
Levallois-Perret, 92300, France
-
Hôpital Privé de la Loire, Ramsay Saint Etienne
Saint-Etienne, 42100, France
-
IATROS International
Bloemfontein, 9301, South Africa
-
IPO do Porto
Porto, 4200-072, Portugal
-
Indo-American Cancer Hospital & Research Center
Hyderabad, Telangana, 500034, India
-
Institut Curie
Paris, 75005, France
-
Institut Régional du Cancer de Montpellier
Montpellier, 34298, France
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
-
Instituto Alexander Fleming
Buenos Aires, 1426, Argentina
-
Instituto Cancerología Medellin
Medellín, 050024, Colombia
-
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, 01246-000, Brazil
-
International Medical Center
Cairo, Egypt
-
K hospital
Hanoi, 100000, Vietnam
-
Katharinenhospital Stuttgart
Stuttgart, 70174, Germany
-
Kings Mill Hospital
Sutton in Ashfield, NG17 4JL, United Kingdom
-
Klinikum am Steinenberg / Ermstalklinik
Reutlingen, 72764, Germany
-
Linksfield Oncology Inc.
Johannesburg, 2192, South Africa
-
Lkh-Univ. Klinikum Graz
Graz, 8036, Austria
-
MOC Cancer Care & Research Centre (Unit of Cellcure Cancer Centre Pvt Ltd)
Mumbai, Maharashtra, 400036, India
-
Manipal Hospital
Bangalore, Karnataka, 560017, India
-
Marien-Hospital Wesel
Wesel, 46483, Germany
-
Max Super Speciality Hospital
New Delhi, National Capital Territory of Delhi, 110017, India
-
Medical Oncology Centre of Rosebank
Johannesburg, 2196, South Africa
-
Medicana International Atasehir Hospital
Istanbul, 34750, Turkey (Türkiye)
-
Medicana International Izmir Hospital
Izmir, 35170, Turkey (Türkiye)
-
Medicana International Zincirlikuyu Hospital
Istanbul, Enter Text, 34394, Turkey (Türkiye)
-
Medicina de Precisión - Celerity
Las Condes, 7560908, Chile
-
Mediclinic City Hospital
Dubai, United Arab Emirates
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany
-
Memorial Ankara Hastanesi
Ankara, 06520, Turkey (Türkiye)
-
Metro Davao Medical and Research Center
Davao City, 8000, Philippines
-
Metropolitan Hospital Fourth Oncology Clinic
Faliro, 185 47, Greece
-
Mid-Land Regional Hospital Tullamore
CO Offaly, R35 NY51, Ireland
-
Mount Vernon Hospital
Northwood, HA6 2RN, United Kingdom
-
Musgrove Park Hospital
Somerset, TA1 5DA, United Kingdom
-
Narodny Onkologicky Ustav
Bratislava, 833 10, Slovakia
-
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie
Warsaw, 02-781, Poland
-
National Guard King Abdulaziz Medical City
Riyadh, 11426, Saudi Arabia
-
North Estonia Medical Centre Foundation
Tallinn, 13419, Estonia
-
ONCARE Viaducto Napoles
Mexico City, Mexico CITY (federal District), 03810, Mexico
-
Oncology Institute of Vojvodina
Kamenitz, 21204, Serbia
-
Oncomed-System
Belgrade, Serbia
-
Organizacion Sanitas Internacional
Bogotá, Colombia
-
Orszagos Onkologiai Intezet
Budapest, 1122, Hungary
-
Praxis für Hämatologie, Onkologie und Palliativmedizin
Mönchengladbach, 41066, Germany
-
Pécsi Tudományegyetem
Pécs, 7623, Hungary
-
Royal Devon & Exeter Hospital
Exeter, EX2 5DW, United Kingdom
-
Royal Surrey County Hospital
Guildford, GU2 7XX, United Kingdom
-
Royal Sussex County Hospital
Eastbourne, BN2 1ES, United Kingdom
-
SIRIUS Medical
Belgrade, Serbia
-
SLK-Kliniken Heilbronn GmbH;Klinik für Innere Medizin III
Heilbronn, 74078, Germany
-
Sourasky / Ichilov Hospital
Tel Aviv, 6423906, Israel
-
Special hospital for internal diseases Vesalius
Belgrade, Serbia
-
St Georges University Hospitals NHS Foundation Trust
London, SW17 0RE, United Kingdom
-
St James's Hospital
Dublin, 8, Ireland
-
St Lukes Medical Center
Quezon City, 1102, Philippines
-
St Vincent'S Uni Hospital
Dublin, 4, Ireland
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
-
Tartu Uni Hospital
Tartu, 51014, Estonia
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400012, India
-
Tawam Hospital
Al Ain City, 15258, United Arab Emirates
-
The American British Cowdray Hospital/ Hospital Abc
Mexico City, 01120, Mexico
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
Torbay Hospital
Torquay, TQ2 7AA, United Kingdom
-
Trakya University Medical Faculty
Edirne, 22030, Turkey (Türkiye)
-
University Clinic Golnik
Golnik, 4204, Slovenia
-
University Hospital Medical Center Bezanijska kosa
Belgrade, 11080, Serbia
-
Universitätsklinikum Halle (Saale)
Halle, 06120, Germany
-
Wilgers Oncology Centre
Pretoria, 0001, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
- Can a new drug shield kidneys from chemotherapy damage?
- Mining Responders' tumors for clues to a universal cancer therapy
- Proton boost radiotherapy aims to hit large tumors harder while sparing healthy tissue
- New antibody aims to preserve immune checkpoint while fighting cancer
- Engineered immune cells target two markers on Hard-to-Treat tumors